CONSUMER FRAUD

The End May Be Near for Theranos & Elizabeth Holmes

Four years ago, Theranos was a $10 billion company poised to turn a breakthrough blood testing technology into a diagnostics dynamo to the tune of $70 billion in annual sales. Today, the company and its founding CEO are on the brink of ruin.

The latest and most devastating blow came in recent weeks when a federal grand jury indicted Theranos CEO Elizabeth Holmes and former COO Sunny Balwani on nine counts of wire fraud and two counts of conspiracy, charges carrying a potential sentence of 20 years in prison, fines of $250,000 per count and restitution.

According to prosecutors, “Holmes and Balwani used advertisements and solicitations to encourage and induce doctors and patients to use Theranos’ blood testing laboratory services,” all the while knowing that its touted fingerprick blood tests could not consistently produce accurate and reliable results.

Meanwhile, The Wall Street Journal reports that Theranos is headed for bankruptcy.

Three months ago, it appeared that Holmes and the company she founded in 2013 might be out of the woods when they settled stock fraud charges with the Securities and Exchange Commission.

CLOSE TO VIEW ARTICLE x

You have 3 articles left to view this month.

Your 3 Free Articles Per Month Goes Very Quickly!
Get a 3 month Premium Membership to
one of our G2 Newsletters for just $47!

Click on one of the Newsletters below to sign up now and get unlimited access to all articles, archives, and tools for that specific newsletter!

Close

EMAIL ADDRESS


PASSWORD
EMAIL ADDRESS

FIRST NAME

LAST NAME

TITLE

COMPANY

CITY / STATE

Try Premium Membership

(-0000g2)